ADmit Therapeutics, SL
Carrer Feixa Llarga (Edifici Consorci Biopol) s/n 08907 L'Hospitalet de Llobregat
http://www.admit-therapeutics.com
ADmit Therapeutics is a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL), and focused on the development and commercialization of a novel Alzheimer's disease (AD) early detection technology.
Minority stake unknown %
Investors: European Innovation Council
Minority stake unknown %
Investors: Capitall Cell
Minority stake unknown %
Investors: BSTARTUP, SHIP2B, Genesis Biomed, Equity4Good
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
We are continually updating our list of new startups so please let us know if you have recently started one.
It is a Catalan Government project offering updated information on the Catalan startup ecosystem; gathering and consolidating data from internal databases as well as other local and international sources.